Clinical trials
Low Back Pain trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
238 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 12 |
| 2019 | 9 |
| 2020 | 12 |
| 2021 | 29 |
| 2022 | 24 |
| 2023 | 33 |
| 2024 | 35 |
| 2025 | 51 |
| 2026 | 22 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 162 |
| Unknown status | 27 |
| Recruiting | 20 |
| Not yet recruiting | 18 |
| Active, not recruiting | 5 |
| Enrolling by invitation | 4 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hacettepe University | 18 |
| Uskudar University | 13 |
| Istanbul Medipol University Hospital | 11 |
| Gazi University | 7 |
| Kirsehir Ahi Evran Universitesi | 7 |
| Marmara University | 7 |
| Hasan Kalyoncu University | 6 |
| Istanbul University - Cerrahpasa | 6 |
| Bahçeşehir University | 5 |
| Karabuk University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Low Back Pain | 238 |
| Pain | 19 |
| Intervertebral Disc Displacement | 18 |
| Chronic Pain | 14 |
| Neck Pain | 13 |
| Back Pain | 9 |
| Radiculopathy | 8 |
| Kinesiophobia | 7 |
| Bronchiolitis Obliterans Syndrome | 5 |
| Intervertebral Disc Degeneration | 5 |
Trials
Showing 1 to 25 of 238. Each trial links to its page on Pharma Observatory.
138 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.